Incyte Corporation

Incyte’s goal is to become a leading global biopharmaceutical company. Incyte is a company founded on the premise that investment in good science and the rigorous pursuit of R&D excellence can translate into new medicines that can positively affect patients’ lives.Our therapeutic focus is primarily oncology. We believe the future of cancer treatment lies with immune therapies, which seek to recruit the patient’s own immune system to tackle cancer, and with targeted therapies, which aim to block the effects of cancer-causing mutations. In addition to our marketed products, we have a broad and diversified selection of clinical candidates in our growing portfolio, from both our own laboratories and from partners via licensing transactions.

Bank Name Incyte Corporation
Stock Exchange NASDAQ
Symbol INCY
Sector Healthcare
Industry Biotechnology: Commercial Physical
Country United States
World Region Amarica
Chairman Mr. Hervé Hoppenot
CEO Mr. Hervé Hoppenot
Employees 1208
Website www.incyte.com
Registered Year 1991

UpdateContent
UpdateContent
UpdateContent